Can statins unlock the secrets of a rare liver disease?
NCT ID NCT05912387
First seen Feb 28, 2026 · Last updated Apr 30, 2026 · Updated 8 times
Summary
This study looks at how statin therapy changes bile acids and gut bacteria in people with primary sclerosing cholangitis (PSC), a liver disease with no cure. Researchers will collect samples from 15 adults with PSC to understand the disease better. The goal is not to treat PSC directly, but to gather clues that could lead to future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SCLEROSING CHOLANGITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford University
RECRUITINGStanford, California, 94305, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.